首页 > 最新文献

Infusion & Chemotherapy最新文献

英文 中文
Medical secrecy: the rights and responsibilities of participants of the medical process 医疗保密:医疗过程参与者的权利和责任
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-172-174
N. Lisnevska
Background. Medical secrecy (MS) is a set of information about the disease, its treatment, the results of examinations, which became known to certain healthcare workers (HCW) during their professional activities. The attending physician and the nurse who performs the drug administration are most aware of the patient’s condition. The information included in the MS is divided into two types: medical and personal information of the patient, which became known during the performance of medical professional duties. Objective. To describe selected aspects of the MS problem. Materials and methods. Analysis of the legal framework. Results and discussion. Medical information belongs to professional confidential information and should not be disclosed. Even the information about the very fact of seeking medical care belongs to professional confidential information. Unlawful intentional disclosure of MS by a person to whom it became known in the course of its professional duties entails criminal liability. This applies not only to HCW, but also to other staff of medical institutions. It is possible to provide information about the treatment and even the patient’s stay in the hospital to third parties, including relatives of any degree of kinship, only with the patient’s own consent. Exceptions include cases of extreme urgency, such as when a patient is taken to hospital unconscious and relatives can provide information on existing allergies and comorbidities. Of course, in such cases, the necessary disclosure limits should be followed. If a relative or other person wishes to visit a patient in the hospital, he or she should be contacted in person and visited only with personal consent. With regard to law enforcement officers, the answer to the question of whether a particular patient is treated in this institution should be given only in the presence of criminal proceedings and after resolving this issue with the chief physician. It should be noted that medical information concerning the deceased is also confidential and cannot be disclosed. It should not be assumed that the deceased can no longer be harmed, so any liability will be absent. Disclosure of such information is also a crime, on the basis of which criminal proceedings may be started. Recently, the medical legislation in Ukraine was changed, and as of today, the fine for disclosing MT is over UAH 50,000. When treating patients with disabilities, all necessary information should be provided to their parents or carers. When treating children aged 14-18, it is impossible not to provide information about treatment to parents, although this may be contrary to the wishes of the child. An important issue is the provision of information to children who are incapacitated by age, but legally capable. If a 5-year-old child asks questions about his or her health, a doctor or other HCW must answer them in a form that is accessible. A similar situation occurs with mentally ill patients: they are deprived of
背景。医疗保密(MS)是一组关于疾病、治疗、检查结果的信息,这些信息是某些保健工作者(HCW)在其专业活动中知道的。主治医生和给药的护士最了解病人的病情。MS中包含的信息分为两类:患者的医疗信息和个人信息,这些信息是在履行医疗专业职责过程中获知的。目标。描述MS问题的某些方面。材料和方法。法律框架分析。结果和讨论。医疗信息属于专业保密信息,不得外泄。甚至有关求医的信息本身也属于专业机密信息。在履行专业职责过程中知悉MS的人士非法故意披露MS,须负刑事责任。这不仅适用于医务人员,也适用于医疗机构的其他工作人员。只有在患者本人同意的情况下,才可以向第三方,包括任何程度的亲属提供有关治疗甚至患者住院情况的信息。例外情况包括极端紧急的情况,例如当患者被送往医院时失去意识,亲属可以提供有关现有过敏和合并症的信息。当然,在这种情况下,应遵守必要的披露限制。如果亲属或其他人希望在医院探望病人,应亲自与他或她联系,并在征得本人同意的情况下探视。关于执法人员,对于某一特定病人是否在该机构接受治疗的问题,只有在有刑事诉讼的情况下,并在与主任医生解决这一问题之后,才能给出答案。应当指出,有关死者的医疗资料也是保密的,不能透露。不应假定死者不再受到伤害,因此将不存在任何责任。披露这类信息也是一种犯罪,可据此提起刑事诉讼。最近,乌克兰的医疗立法发生了变化,截至今天,披露MT的罚款超过UAH 50,000。在治疗残疾患者时,应向其父母或照顾者提供所有必要的信息。在治疗14-18岁的儿童时,不可能不向父母提供有关治疗的信息,尽管这可能与儿童的意愿相反。一个重要的问题是向因年龄而丧失行为能力但在法律上有能力的儿童提供信息。如果5岁儿童询问有关其健康的问题,医生或其他卫生工作者必须以易于获取的形式回答。精神病人也有类似的情况:他们被剥夺了法律行为能力,但他们有权了解自己的健康状况。你也应该非常小心地保存医疗记录。例如,关于病毒感染(肝炎、艾滋病毒/艾滋病)的信息不应该放在病史的封面上,而应该放在里面。结论:1。MS信息分为两类:患者的医疗信息和个人信息。2. 医疗信息属于专业保密信息,不得外泄。3.只有在患者本人同意的情况下,才可以向包括亲属在内的第三方提供有关治疗甚至患者住院情况的信息。4. 在治疗残疾病人时,应向其父母或照顾者提供所有必要的信息。
{"title":"Medical secrecy: the rights and responsibilities of participants of the medical process","authors":"N. Lisnevska","doi":"10.32902/2663-0338-2020-3.2-172-174","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-172-174","url":null,"abstract":"Background. Medical secrecy (MS) is a set of information about the disease, its treatment, the results of examinations, which became known to certain healthcare workers (HCW) during their professional activities. The attending physician and the nurse who performs the drug administration are most aware of the patient’s condition. The information included in the MS is divided into two types: medical and personal information of the patient, which became known during the performance of medical professional duties. \u0000Objective. To describe selected aspects of the MS problem. \u0000Materials and methods. Analysis of the legal framework. \u0000Results and discussion. Medical information belongs to professional confidential information and should not be disclosed. Even the information about the very fact of seeking medical care belongs to professional confidential information. Unlawful intentional disclosure of MS by a person to whom it became known in the course of its professional duties entails criminal liability. This applies not only to HCW, but also to other staff of medical institutions. It is possible to provide information about the treatment and even the patient’s stay in the hospital to third parties, including relatives of any degree of kinship, only with the patient’s own consent. Exceptions include cases of extreme urgency, such as when a patient is taken to hospital unconscious and relatives can provide information on existing allergies and comorbidities. Of course, in such cases, the necessary disclosure limits should be followed. If a relative or other person wishes to visit a patient in the hospital, he or she should be contacted in person and visited only with personal consent. With regard to law enforcement officers, the answer to the question of whether a particular patient is treated in this institution should be given only in the presence of criminal proceedings and after resolving this issue with the chief physician. It should be noted that medical information concerning the deceased is also confidential and cannot be disclosed. It should not be assumed that the deceased can no longer be harmed, so any liability will be absent. Disclosure of such information is also a crime, on the basis of which criminal proceedings may be started. Recently, the medical legislation in Ukraine was changed, and as of today, the fine for disclosing MT is over UAH 50,000. When treating patients with disabilities, all necessary information should be provided to their parents or carers. When treating children aged 14-18, it is impossible not to provide information about treatment to parents, although this may be contrary to the wishes of the child. An important issue is the provision of information to children who are incapacitated by age, but legally capable. If a 5-year-old child asks questions about his or her health, a doctor or other HCW must answer them in a form that is accessible. A similar situation occurs with mentally ill patients: they are deprived of","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83424691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pain syndromes in endometriosis: an integrated approach to the problem management 子宫内膜异位症的疼痛综合征:问题管理的综合方法
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-271-273
T. Tatarchuk
Background. Endometriosis affects 10 % of women of reproductive age. Endometriosis is often accompanied by the following symptoms: dyspareunia, pelvic pain, and dysmenorrhea. Pain is a leading symptom of endometriosis and often persists despite treatment. Objective. To elucidate the basics of pathogenesis and treatment of pain in endometriosis. Materials and methods. Analysis of literature data on this topic; own study involving 64 women with endometriosis. Group 1 was given dienogest (2 mg per day) for 3 months, and group 2 was given dienogest in combination with Tivortin (5 intravenous infusions of 100 ml each other day with the switch to Tivortin aspartate (“Yuria-Pharm”) orally). Results and discussion. Pain in endometriosis includes several pathophysiological mechanisms: increased nociception, inflammation, and changes in the recognition of pain in the nervous system. Significant pelvic vascularization promotes the rapid transmission of pain signals from this area to the brain. The severity of pain noted by women poorly correlates with the degree of disease detected during surgery. According to the recommendations of NICE (2017), one or more of the following symptoms are sufficient for suspected endometriosis: chronic pelvic pain (>6 months), dysmenorrhea, which adversely affects quality of life and daily activity, dyspareunia, gastrointestinal disorders and urinary system symptoms associated with menstruation, and infertility in combination with one or more of the above symptoms. Endometriosis requires flexible adaptation of management and the constant choice of treatment tactics depending on the symptoms and life situation of the patient. The basic goals of treatment inlude elimination of symptoms, restoration of quality of life and fertility, prevention of recurrences and repeated surgical intervention. Analgesics, neuromodulators and hormonal agents are used for pharmacological pain management. Additional and alternative methods include reflexology, manual therapy, osteopathy, exercise, dietary changes, and sleep hygiene. Elimination of the oxidation imbalance is one of the methods to treat pain in endometriosis. The uterus is a highly vascularized organ and its cells are constantly affected by high concentrations of oxygen. In settings of hypoxia, steroidogenesis, angiogenesis, inflammation and metabolic transition occur in endometrial cells. In women with endometriosis, there is an increase in markers of oxidative stress in the blood. Intrauterine oxidative stress can be eliminated with the powerful antioxidant L-arginine (Tivortin, “Yuria-Pharm”). In our own study, it was shown that the inclusion of Tivortin into the treatment allowed to decrease the intensity of intermenstrual endometriosis-associated pelvic pain more markedly than the standard treatment. The initial pain level was 61.32±3.2 according to the visual-analog scale in group 1 and 64.2±2.8 in group 2 (Tivortin). A month later, the indicators were 36.5±2.6 and 27.2±2.2,
背景。子宫内膜异位症影响10%的育龄妇女。子宫内膜异位症常伴有以下症状:性交困难、盆腔疼痛和痛经。疼痛是子宫内膜异位症的主要症状,尽管治疗,疼痛仍然存在。目标。目的:探讨子宫内膜异位症疼痛的发病机制及治疗方法。材料和方法。本课题的文献资料分析;对64名患有子宫内膜异位症的女性的研究。组1给予地诺孕素(2 mg / d),连用3个月;组2给予地诺孕素联合替沃汀(5次静脉滴注,每隔一天100 ml,切换为天冬氨酸替沃汀(“Yuria-Pharm”)口服)。结果和讨论。子宫内膜异位症的疼痛包括几种病理生理机制:痛觉增加、炎症和神经系统对疼痛识别的改变。明显的骨盆血管形成促进疼痛信号从该区域快速传递到大脑。妇女注意到的疼痛严重程度与手术中发现的疾病程度相关性不大。根据NICE(2017)的建议,以下一种或多种症状足以诊断疑似子宫内膜异位症:慢性盆腔疼痛(>6个月)、对生活质量和日常活动产生不利影响的痛经、性交困难、与月经相关的胃肠道疾病和泌尿系统症状,以及合并上述一种或多种症状的不孕症。子宫内膜异位症需要根据患者的症状和生活状况灵活适应治疗和不断选择治疗策略。治疗的基本目标包括消除症状,恢复生活质量和生育能力,预防复发和反复手术干预。镇痛药,神经调节剂和激素制剂用于药物疼痛管理。其他替代方法包括反射疗法、手工疗法、整骨疗法、运动、饮食改变和睡眠卫生。消除氧化失衡是治疗子宫内膜异位症疼痛的方法之一。子宫是一个高度血管化的器官,其细胞经常受到高浓度氧气的影响。在缺氧的情况下,子宫内膜细胞会发生类固醇生成、血管生成、炎症和代谢转变。在患有子宫内膜异位症的女性中,血液中的氧化应激标志物增加。宫内氧化应激可以通过强大的抗氧化剂l -精氨酸(Tivortin,“Yuria-Pharm”)消除。在我们自己的研究中,研究表明,与标准治疗相比,将Tivortin纳入治疗可以更显著地降低月经期间子宫内膜异位症相关盆腔疼痛的强度。根据视觉模拟量表,1组患者初始疼痛水平为61.32±3.2,2组患者初始疼痛水平为64.2±2.8 (Tivortin)。1个月后,各指标分别为36.5±2.6和27.2±2.2。值得注意的是,替沃汀的效果是稳定的。标准治疗组疼痛强度在治疗结束后再次升高,而Tivortin组疼痛强度维持在较低水平。对McGill问卷结果的评估显示,在Tivortin组中,疼痛不仅由于疼痛的实际强度而减轻,而且由于其感觉和情绪特征的减少。治疗后,1组月经出血强度明显增加。结论:1。子宫内膜异位症治疗的目标是消除症状,恢复生活质量和生育能力,防止复发和重复手术。2. l -精氨酸(Tivortin)治疗子宫内膜异位症的有效性是通过使盆腔器官血管张力正常化,减少氧化应激,精神稳定作用,增加中性粒细胞的抗菌活性来保证的。3.替沃汀是治疗子宫内膜异位症和预防其复发的一个有前途的领域。
{"title":"Pain syndromes in endometriosis: an integrated approach to the problem management","authors":"T. Tatarchuk","doi":"10.32902/2663-0338-2020-3.2-271-273","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-271-273","url":null,"abstract":"Background. Endometriosis affects 10 % of women of reproductive age. Endometriosis is often accompanied by the following symptoms: dyspareunia, pelvic pain, and dysmenorrhea. Pain is a leading symptom of endometriosis and often persists despite treatment. \u0000Objective. To elucidate the basics of pathogenesis and treatment of pain in endometriosis. \u0000Materials and methods. Analysis of literature data on this topic; own study involving 64 women with endometriosis. Group 1 was given dienogest (2 mg per day) for 3 months, and group 2 was given dienogest in combination with Tivortin (5 intravenous infusions of 100 ml each other day with the switch to Tivortin aspartate (“Yuria-Pharm”) orally). \u0000Results and discussion. Pain in endometriosis includes several pathophysiological mechanisms: increased nociception, inflammation, and changes in the recognition of pain in the nervous system. Significant pelvic vascularization promotes the rapid transmission of pain signals from this area to the brain. The severity of pain noted by women poorly correlates with the degree of disease detected during surgery. According to the recommendations of NICE (2017), one or more of the following symptoms are sufficient for suspected endometriosis: chronic pelvic pain (>6 months), dysmenorrhea, which adversely affects quality of life and daily activity, dyspareunia, gastrointestinal disorders and urinary system symptoms associated with menstruation, and infertility in combination with one or more of the above symptoms. Endometriosis requires flexible adaptation of management and the constant choice of treatment tactics depending on the symptoms and life situation of the patient. The basic goals of treatment inlude elimination of symptoms, restoration of quality of life and fertility, prevention of recurrences and repeated surgical intervention. Analgesics, neuromodulators and hormonal agents are used for pharmacological pain management. Additional and alternative methods include reflexology, manual therapy, osteopathy, exercise, dietary changes, and sleep hygiene. Elimination of the oxidation imbalance is one of the methods to treat pain in endometriosis. The uterus is a highly vascularized organ and its cells are constantly affected by high concentrations of oxygen. In settings of hypoxia, steroidogenesis, angiogenesis, inflammation and metabolic transition occur in endometrial cells. In women with endometriosis, there is an increase in markers of oxidative stress in the blood. Intrauterine oxidative stress can be eliminated with the powerful antioxidant L-arginine (Tivortin, “Yuria-Pharm”). In our own study, it was shown that the inclusion of Tivortin into the treatment allowed to decrease the intensity of intermenstrual endometriosis-associated pelvic pain more markedly than the standard treatment. The initial pain level was 61.32±3.2 according to the visual-analog scale in group 1 and 64.2±2.8 in group 2 (Tivortin). A month later, the indicators were 36.5±2.6 and 27.2±2.2,","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80922440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications of the infusion therapy and their prevention 输液治疗的并发症及预防
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-45-47
O. Halushko
Background. Infusion solutions are divided into several groups: crystalloids, colloids (natural and artificial), polyatomic alcohols, special drugs (infusion antibiotics, analgesics, hemostatics). Each solution type has its own complications. Objective. To identify the main complications of infusions and prevention measures. Materials and methods. Analysis of the available literature on this topic. Results and discussion. After the transfusion of 1 liter of 0.9 % NaCl only 275 ml of this solution remains in plasma, and 725 ml passes into the interstitial space, causing edema. In addition, there is a risk of hyperchloraemic acidosis in case of massive transfusions. 0.9 % NaCl is inadequate in its ionic composition, has no reserve alkalinity, deepens hyperosmolar changes, so it is not used as monotherapy in daily practice. It is used as a solvent only. Ringer’s solution is also easily excreted into the interstitial space with the edema formation. It is hyperosmolar, contains a large number of chlorine ions and is excreted by the kidneys, so it should be used with caution in patients with kidney disease. A number of drugs (aminocaproic acid, amphotericin B, blood products, sodium thiopental) are incompatible with Ringer’s solution and Ringer’s lactate. In turn, 5 % glucose solution is ineffective for detoxification, liver cirrhosis and restoring the circulating blood volume in case of blood loss. Glucose infusions can increase the production of carbon dioxide and lactate, increase ischemic damage to the brain and other organs, and promote tissue edema. At present, the routine use of glucose during surgery and in critically ill patients has been completely abandoned. Preparations of polyatomic alcohols can be divided into the preparations of six-atomic alcohols – mannitol (Mannit) and sorbitol (Sorbilact, Reosorbilact) and five-atomic alcohols (xylitol – Xylate, Gluxyl, Lactoxyl) (all of the listed solutions are made by “Yuria-Pharm”). Side effects of mannitol include tachycardia, thrombophlebitis, chest pain, skin rash, dehydration, dyspepsia, fluid and electrolyte balance, and hallucinations. Hypotension is the most common complication of mannitol usage. Reosorbilact is a modern balanced infusion solution. Its effects include the hypovolemia correction, restoration of electrolyte disturbances, normalization of cardiac activity and nerve conduction, increase of alkaline blood reserve and restoration of energy balance. In case of the significant overdose Reosorbilact can cause alkalosis. Contraindications to its administration include alkalosis, cerebral hemorrhage, pulmonary embolism, and 3 grade hypertension. Xylitol is a five-atom alcohol that is rapidly incorporated into the pentose phosphate metaboliс pathway. Its side effects include the allergic reactions, hypertension, nausea, and lactic acidosis. The main disadvantage of hydroxyethyl starch (HES) drugs is the adverse effect on hemostasis (especially in drugs of the first generation). In a
背景。输液液分为几类:晶体、胶体(天然和人工)、多原子醇、特殊药物(输液抗生素、镇痛药、止血药)。每种解决方案类型都有其自身的复杂性。目标。查明输液的主要并发症及预防措施。材料和方法。分析关于这一主题的现有文献。结果和讨论。输注1升0.9%氯化钠后,血浆中仅残留275毫升氯化钠,725毫升氯化钠进入组织间隙,引起水肿。此外,大量输血有发生高氯血症酸中毒的危险。0.9% NaCl的离子组成不足,没有储备碱度,会加深高渗变化,因此在日常实践中不作为单一疗法使用。它只用作溶剂。随着水肿的形成,林格氏液也容易排泄到间隙中。它是高渗透性的,含有大量的氯离子,由肾脏排出,所以有肾脏疾病的患者要慎用。许多药物(氨基己酸、两性霉素B、血液制品、硫喷妥钠)与林格氏液和乳酸林格氏液不相容。反过来,5%葡萄糖溶液对解毒、肝硬化和在失血时恢复循环血容量无效。葡萄糖输注可增加二氧化碳和乳酸的产生,增加脑和其他器官的缺血性损伤,促进组织水肿。目前,在外科手术和危重患者中,葡萄糖的常规使用已被完全放弃。多原子醇的制备可分为六原子醇-甘露醇(mannitit)和山梨醇(Sorbilact, Reosorbilact)和五原子醇(木糖醇- Xylate, Gluxyl, Lactoxyl)的制备(所有列出的溶液均由“Yuria-Pharm”制造)。甘露醇的副作用包括心动过速、血栓性静脉炎、胸痛、皮疹、脱水、消化不良、液体和电解质平衡以及幻觉。低血压是使用甘露醇最常见的并发症。Reosorbilact是一种现代平衡输液溶液。其作用包括纠正低血容量,恢复电解质紊乱,使心脏活动和神经传导正常化,增加碱性血液储备和恢复能量平衡。在大量过量的情况下,可引起碱中毒。禁忌症包括碱中毒、脑出血、肺栓塞和3级高血压。木糖醇是一种五原子醇,可迅速并入戊糖磷酸代谢途径。其副作用包括过敏反应、高血压、恶心和乳酸性酸中毒。羟乙基淀粉(HES)类药物的主要缺点是对止血有不良影响(尤其是第一代药物)。此外,HES可能会损害肾功能,因此应在最短的时间内以最低的有效剂量使用。除了与输液相关的并发症外,还有与注射过程相关的并发症(血肿、浸润、血栓栓塞、空气栓塞和静脉炎)。为防止输液治疗各阶段的并发症,需要进行彻底的监测。应监测血压、心率、血气成分、毛细血管充盈时间、精神状态、利尿等参数。还要仔细检查处方药的组成和用药说明书,控制输液速度,合理组合不同的药物。结论:1。输液液有好几类,每一类都有自己的优点和缺点。2. Reosorbilact是一种平衡的药物,副作用风险最小。3.为防止并发症的发生,需要监测基本生理参数,控制输液速度,合理组合使用不同的工具。
{"title":"Complications of the infusion therapy and their prevention","authors":"O. Halushko","doi":"10.32902/2663-0338-2020-3.2-45-47","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-45-47","url":null,"abstract":"Background. Infusion solutions are divided into several groups: crystalloids, colloids (natural and artificial), polyatomic alcohols, special drugs (infusion antibiotics, analgesics, hemostatics). Each solution type has its own complications. \u0000Objective. To identify the main complications of infusions and prevention measures. \u0000Materials and methods. Analysis of the available literature on this topic. \u0000Results and discussion. After the transfusion of 1 liter of 0.9 % NaCl only 275 ml of this solution remains in plasma, and 725 ml passes into the interstitial space, causing edema. In addition, there is a risk of hyperchloraemic acidosis in case of massive transfusions. 0.9 % NaCl is inadequate in its ionic composition, has no reserve alkalinity, deepens hyperosmolar changes, so it is not used as monotherapy in daily practice. It is used as a solvent only. Ringer’s solution is also easily excreted into the interstitial space with the edema formation. It is hyperosmolar, contains a large number of chlorine ions and is excreted by the kidneys, so it should be used with caution in patients with kidney disease. A number of drugs (aminocaproic acid, amphotericin B, blood products, sodium thiopental) are incompatible with Ringer’s solution and Ringer’s lactate. In turn, 5 % glucose solution is ineffective for detoxification, liver cirrhosis and restoring the circulating blood volume in case of blood loss. Glucose infusions can increase the production of carbon dioxide and lactate, increase ischemic damage to the brain and other organs, and promote tissue edema. At present, the routine use of glucose during surgery and in critically ill patients has been completely abandoned. Preparations of polyatomic alcohols can be divided into the preparations of six-atomic alcohols – mannitol (Mannit) and sorbitol (Sorbilact, Reosorbilact) and five-atomic alcohols (xylitol – Xylate, Gluxyl, Lactoxyl) (all of the listed solutions are made by “Yuria-Pharm”). Side effects of mannitol include tachycardia, thrombophlebitis, chest pain, skin rash, dehydration, dyspepsia, fluid and electrolyte balance, and hallucinations. Hypotension is the most common complication of mannitol usage. Reosorbilact is a modern balanced infusion solution. Its effects include the hypovolemia correction, restoration of electrolyte disturbances, normalization of cardiac activity and nerve conduction, increase of alkaline blood reserve and restoration of energy balance. In case of the significant overdose Reosorbilact can cause alkalosis. Contraindications to its administration include alkalosis, cerebral hemorrhage, pulmonary embolism, and 3 grade hypertension. Xylitol is a five-atom alcohol that is rapidly incorporated into the pentose phosphate metaboliс pathway. Its side effects include the allergic reactions, hypertension, nausea, and lactic acidosis. The main disadvantage of hydroxyethyl starch (HES) drugs is the adverse effect on hemostasis (especially in drugs of the first generation). In a","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87847930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Four D concept of fluid therapy 4d流体疗法概念
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-193-195
M. Mulbrain
Background. D (definition): the daily fluid balance is the sum of all the amounts of consumed and excreted fluid. Assessment of fluid accumulation per day allows to detect fluid overload. At early stages (the first 1-3 hours) of infusion therapy (IT) targeted administration of necessary drugs should be carried out. The volume of infusion is 10-30 ml/kg of body weight. Subsequently, during the first week of treatment in the intensive care unit (ICU) it is necessary to achieve two consecutive days with a negative fluid balance. In the later stages of treatment, active fluid removal is performed with diuretics or renal replacement therapy. The concept of four D IT actually includes seven D: definitions, diagnosis, drug, dose, duration, de-escalation, discharge. Objective. To describe the basic principles of modern IT. Materials and methods. Analysis of literature sources on this topic. Results and discussion. The improvement and proper application of the existing IT techniques and drugs is an important step in improving treatment outcomes. Frequent mistakes include too long IT, wrong choice of drug or dose. Hypervolemia as a result of excessive infusions is even more dangerous than hypovolemia because it can lead to the interstitial edema. To address the issue of IT, it is advisable to focus on preload – the degree of stretching of a cardiomyocyte before contraction. Echocardiographic indicators of preload include end-diastolic volume and end-diastolic pressure of left ventricle. When choosing a solution for IT, it is necessary to take into account its tonicity and osmolality, as it depends on whether the solution will remain in the vessels or enter the intercellular space. Choosing an optimal IT, one should take into account the choice of solution or combination of solutions, the optimal time and duration of its introduction, the pathological condition of the patient. Thus, in case of trauma, blood and crystalloids are prescribed, in case of sepsis – crystalloids, and later albumin, in the perioperative period – hydroxyethyl starch (HES) and crystalloids. When choosing an antibiotic for IT, you should pay attention to the recent history of hospitalizations, length of stay in a medical institution (term >5 days increases the likelihood that the patient’s infection is nosocomial), comorbid conditions, history of steroid use, previous antibiotic therapy (ABT), duration of mechanical lung ventilation. Dose is another important aspect of IT. In ABT, too high dose can be toxic to the macroorganism, and too low dose can be ineffective and cause bacterial resistance. When selecting the dose of the antibiotic, attention should be paid to the distribution volume of the drug, the liver and kidney function and the peculiarities of the drug clearance, albumin level, ability to penetrate into tissues, minimal inhibitory concentration. In turn, when selecting the dose of solutions for IT, it is necessary to take into account the volume of distribution, type of
背景。D(定义):每日液体平衡是所有消耗和排泄液体量的总和。每天液体积累的评估允许检测液体过载。在输注治疗(IT)的早期阶段(前1-3小时),应进行必要药物的靶向给药。输注量为10- 30ml /kg体重。随后,在重症监护病房(ICU)治疗的第一周,有必要连续两天保持体液负平衡。在治疗的后期,采用利尿剂或肾脏替代疗法主动清除液体。4d IT的概念实际上包括七个D:定义、诊断、药物、剂量、持续时间、降级、出院。目标。描述现代资讯科技的基本原理。材料和方法。对这一主题的文献来源进行分析。结果和讨论。对现有信息技术和药物的改进和合理应用是提高治疗效果的重要一步。常见的错误包括信息太长,选择错误的药物或剂量。过量输液引起的高血容量甚至比低血容量更危险,因为它可导致间质水肿。为了解决IT问题,建议关注预负荷-收缩前心肌细胞的拉伸程度。预负荷的超声心动图指标包括左心室舒张末期容积和舒张末期压。在选择IT解决方案时,有必要考虑它的滋补性和渗透性,因为这取决于解决方案是否会留在血管中或进入细胞间空间。选择最佳的IT时,应考虑到溶液或溶液组合的选择,引入的最佳时间和持续时间,以及患者的病理状况。因此,在创伤的情况下,规定血液和晶体,在败血症的情况下-晶体,后来的白蛋白,在围手术期-羟乙基淀粉(HES)和晶体。在选择用于IT的抗生素时,应注意近期的住院史、在医疗机构的住院时间(bbb50天增加患者院内感染的可能性)、合并症、类固醇使用史、既往抗生素治疗(ABT)、机械肺通气持续时间。剂量是IT的另一个重要方面。在ABT中,过高的剂量可能对大型生物体有毒,过低的剂量可能无效并引起细菌耐药性。在选择抗生素的剂量时,应注意药物的分布体积、肝肾功能以及药物清除率、白蛋白水平、穿透组织能力、最小抑制浓度的特点。反过来,在选择IT溶液的剂量时,有必要考虑到分布的体积,溶液的类型,渗透压,强直性和肾功能状况。在大多数情况下,溶液的维持量为1ml /kg/h (25ml /kg/天),复苏所需的体积在前3小时为30ml /kg,液体量为4ml /kg/ 15分钟。一些液体(HES)对肾脏有毒(最大剂量为30ml /kg/h)。然而,缺乏对休克的控制也对肾脏不利,因此应始终评估收益/风险平衡。预负荷的静态替代参数(中心静脉压、平均动脉压、尿量、容量指标)常用于IT滴定。然而,使用血流动力学的动态功能参数更合适:脉压变化、卒中容积变化、被动抬腿试验。最佳信息技术的持续时间尚未确定,尽管有证据表明有下降趋势。在消除休克并使血乳酸正常化后,建议停止it。建议将ABT的持续时间减少到最低限度,并记住目标是治疗感染,而不是治疗发烧、浸润或c反应蛋白升高。因此,当活动性感染的体征和症状消失时,应停用ABT。将来,生物标志物(分别为降钙素原或胱抑素C、瓜氨酸)将用于确定是否需要停止ABT或IT。及时的IT降级与及时的IT启动同等重要。建议遵循ROSE概念(R -复苏;O -器官支持;S -稳定化;E -疏散)。结论:1。4d IT的概念包括定义、诊断、药物、剂量、持续时间、降级和出院。2. 对于IT滴定,合理的使用血流动力学动态功能参数:脉压和冲击量变化,被动抬腿试验。3.建议遵循ROSE的概念。
{"title":"Four D concept of fluid therapy","authors":"M. Mulbrain","doi":"10.32902/2663-0338-2020-3.2-193-195","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-193-195","url":null,"abstract":"Background. D (definition): the daily fluid balance is the sum of all the amounts of consumed and excreted fluid. Assessment of fluid accumulation per day allows to detect fluid overload. At early stages (the first 1-3 hours) of infusion therapy (IT) targeted administration of necessary drugs should be carried out. The volume of infusion is 10-30 ml/kg of body weight. Subsequently, during the first week of treatment in the intensive care unit (ICU) it is necessary to achieve two consecutive days with a negative fluid balance. In the later stages of treatment, active fluid removal is performed with diuretics or renal replacement therapy. The concept of four D IT actually includes seven D: definitions, diagnosis, drug, dose, duration, de-escalation, discharge. \u0000Objective. To describe the basic principles of modern IT. \u0000Materials and methods. Analysis of literature sources on this topic. \u0000Results and discussion. The improvement and proper application of the existing IT techniques and drugs is an important step in improving treatment outcomes. Frequent mistakes include too long IT, wrong choice of drug or dose. Hypervolemia as a result of excessive infusions is even more dangerous than hypovolemia because it can lead to the interstitial edema. To address the issue of IT, it is advisable to focus on preload – the degree of stretching of a cardiomyocyte before contraction. Echocardiographic indicators of preload include end-diastolic volume and end-diastolic pressure of left ventricle. When choosing a solution for IT, it is necessary to take into account its tonicity and osmolality, as it depends on whether the solution will remain in the vessels or enter the intercellular space. Choosing an optimal IT, one should take into account the choice of solution or combination of solutions, the optimal time and duration of its introduction, the pathological condition of the patient. Thus, in case of trauma, blood and crystalloids are prescribed, in case of sepsis – crystalloids, and later albumin, in the perioperative period – hydroxyethyl starch (HES) and crystalloids. When choosing an antibiotic for IT, you should pay attention to the recent history of hospitalizations, length of stay in a medical institution (term >5 days increases the likelihood that the patient’s infection is nosocomial), comorbid conditions, history of steroid use, previous antibiotic therapy (ABT), duration of mechanical lung ventilation. Dose is another important aspect of IT. In ABT, too high dose can be toxic to the macroorganism, and too low dose can be ineffective and cause bacterial resistance. When selecting the dose of the antibiotic, attention should be paid to the distribution volume of the drug, the liver and kidney function and the peculiarities of the drug clearance, albumin level, ability to penetrate into tissues, minimal inhibitory concentration. In turn, when selecting the dose of solutions for IT, it is necessary to take into account the volume of distribution, type of","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87515734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Procedural sedation – a patient’s whim or a necessity? 程序性镇静,是病人的突发奇想还是必须的?
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-89-90
O. E. Domoratskyi
Background. Procedural sedation (PS) is a condition that allows patients to avoid discomfort when undergoing certain painful manipulations on the background of stable hemodynamics and respiration and maintaining the ability to respond adequately to verbal commands or tactile stimulation. PS is most often used in dentistry, maxillofacial surgery, endoscopy, ophthalmology, otorhinolaryngology. Objective. Describe the main features of the PS. Materials and methods. Analysis of literature data on this topic. Results and discussion. Risk groups during PS include patients with cardiovascular decompensation, morbid obesity, obstructive sleep apnea, grade III-IV chronic renal failure, liver decompensation, as well as age over 70. The conditions for safe PS are as follows: all medical staff are trained to provide cardiorespiratory resuscitation; there is a constant quick access to resuscitation equipment; a routine pre-procedure assessment of the patient’s condition (especially the upper respiratory tract) was carried out; pre-procedure fasting was prescribed; careful monitoring of the patient’s condition is provided. The main scales for sedation assessment include Ramsay Sedation Scale, Sedation Agitation Scale, Motor Activity Assessment Scale, Vancouver Interactive and Calmness Scale, Richmond Agitation-Sedation Scale, Adaptation to Intensive Care Environment, Minnesota Sedation Assessment Tool. Midazolam, propofol, dexmedetomidine can be used for PS. Minimal sedation (anxiolysis) is a medical condition in which the patient responds normally to voice commands. Cognitive function and coordination in this condition may be impaired, however, cardiorespiratory function remains unchanged. Such sedation is prescribed in traumatology, maxillofacial surgery, urology, gynecology, plastic surgery. Moderate sedation is a medical suppression of consciousness in which the patient responds to voice commands accompanied by light tactile stimulation. Adequate respiration and functioning of the cardiovascular system is maintained. Diazepam/sibazone, midazolam, dexmedetomidine are prescribed for this purpose. The latter is recommended for fiber-optic intubation in a state of complete consciousness. The dangers of PS include passive aspiration and ventilation disorders, which leads to hypoxia and hypercapnia. Caution should be taken with propofol due to the possible development of respiratory depression and hemodynamics, pain in the vein during administration. Dexmedetomidine does not cause respiratory depression, however, this does not eliminate the need for monitoring. Conclusions. 1. Adequate sedation during surgery is a logical component of the intervention if the regional methods of anesthesia are applicated. 2. Sedation outside the operating room will account for more and more of the use of anesthetics. 3. There is a need for clear regulation of PS. 4. When choosing a drug one should take into account the purpose of its administration, curability of complication
背景。程序性镇静(PS)是在血流动力学和呼吸稳定的背景下,使患者在接受某些痛苦的操作时避免不适,并保持对口头命令或触觉刺激作出充分反应的能力。PS最常用于牙科、颌面外科、内窥镜、眼科、耳鼻喉科。目标。描述PS的主要特点,材料和方法。本课题的文献资料分析。结果和讨论。PS期间的危险人群包括心血管失代偿、病态肥胖、阻塞性睡眠呼吸暂停、III-IV级慢性肾功能衰竭、肝失代偿以及70岁以上的患者。安全PS的条件如下:所有医务人员都经过心肺复苏培训;随时可以快速获得复苏设备;对患者的病情(特别是上呼吸道)进行常规术前评估;术前禁食;对病人的病情进行仔细的监测。镇静评估的主要量表有Ramsay镇静量表、镇静躁动量表、运动活动评估量表、Vancouver互动镇静量表、Richmond躁动镇静量表、重症监护环境适应量表、Minnesota镇静评估工具。咪达唑仑、异丙酚、右美托咪定可用于PS。轻度镇静(抗焦虑)是一种医学状况,患者对语音命令反应正常。在这种情况下,认知功能和协调性可能受损,但心肺功能保持不变。这种镇静剂在创伤科、颌面外科、泌尿科、妇科、整形外科都有使用。中度镇静是一种医学上的意识抑制,患者对伴随着轻微触觉刺激的语音指令做出反应。维持适当的呼吸和心血管系统的功能。地西泮/西巴酮,咪达唑仑,右美托咪定用于此目的。后者建议在完全意识状态下进行光纤插管。PS的危险包括被动吸入和通气障碍,导致缺氧和高碳酸血症。使用异丙酚应谨慎,因为在给药期间可能出现呼吸抑制和血流动力学,静脉疼痛。右美托咪定不会引起呼吸抑制,然而,这并不能消除监测的需要。结论:1。如果采用局部麻醉方法,手术中适当的镇静是干预的逻辑组成部分。2. 手术室外的镇静将占麻醉药使用的越来越多。3.有必要对PS进行明确的监管。在选择药物时,应考虑给药的目的、并发症的可治愈性、患者的舒适度和安全性。
{"title":"Procedural sedation – a patient’s whim or a necessity?","authors":"O. E. Domoratskyi","doi":"10.32902/2663-0338-2020-3.2-89-90","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-89-90","url":null,"abstract":"Background. Procedural sedation (PS) is a condition that allows patients to avoid discomfort when undergoing certain painful manipulations on the background of stable hemodynamics and respiration and maintaining the ability to respond adequately to verbal commands or tactile stimulation. PS is most often used in dentistry, maxillofacial surgery, endoscopy, ophthalmology, otorhinolaryngology. \u0000Objective. Describe the main features of the PS. \u0000Materials and methods. Analysis of literature data on this topic. \u0000Results and discussion. Risk groups during PS include patients with cardiovascular decompensation, morbid obesity, obstructive sleep apnea, grade III-IV chronic renal failure, liver decompensation, as well as age over 70. The conditions for safe PS are as follows: all medical staff are trained to provide cardiorespiratory resuscitation; there is a constant quick access to resuscitation equipment; a routine pre-procedure assessment of the patient’s condition (especially the upper respiratory tract) was carried out; pre-procedure fasting was prescribed; careful monitoring of the patient’s condition is provided. The main scales for sedation assessment include Ramsay Sedation Scale, Sedation Agitation Scale, Motor Activity Assessment Scale, Vancouver Interactive and Calmness Scale, Richmond Agitation-Sedation Scale, Adaptation to Intensive Care Environment, Minnesota Sedation Assessment Tool. Midazolam, propofol, dexmedetomidine can be used for PS. Minimal sedation (anxiolysis) is a medical condition in which the patient responds normally to voice commands. Cognitive function and coordination in this condition may be impaired, however, cardiorespiratory function remains unchanged. Such sedation is prescribed in traumatology, maxillofacial surgery, urology, gynecology, plastic surgery. Moderate sedation is a medical suppression of consciousness in which the patient responds to voice commands accompanied by light tactile stimulation. Adequate respiration and functioning of the cardiovascular system is maintained. Diazepam/sibazone, midazolam, dexmedetomidine are prescribed for this purpose. The latter is recommended for fiber-optic intubation in a state of complete consciousness. The dangers of PS include passive aspiration and ventilation disorders, which leads to hypoxia and hypercapnia. Caution should be taken with propofol due to the possible development of respiratory depression and hemodynamics, pain in the vein during administration. Dexmedetomidine does not cause respiratory depression, however, this does not eliminate the need for monitoring. \u0000Conclusions. 1. Adequate sedation during surgery is a logical component of the intervention if the regional methods of anesthesia are applicated. 2. Sedation outside the operating room will account for more and more of the use of anesthetics. 3. There is a need for clear regulation of PS. 4. When choosing a drug one should take into account the purpose of its administration, curability of complication","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77081098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient care after surgery: suture care and wound care process 术后患者护理:缝线护理和伤口护理过程
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-138-140
О. Kovalenko
Background. A wound is a defect of skin and underlying tissues that can be caused by many factors. Wound care is more than just changing dressings. Different wounds require different approaches and care. Optimal wound care supports the natural healing process in an effective but gentle way. Wounds are classified into acute and chronic, as well as cut, scalped, chopped, stabbed, bruised, torn, bitten, gunshot, and surgical. Surgical wounds are distinguished by the fact that they are applied specifically, for medical or diagnostic purposes, in special aseptic conditions, with minimal tissue trauma, in conditions of anesthesia, with thorough hemostasis and joining of separated anatomical structures with sutures. Objective. To describe the modern approach to wound care. Materials and methods. Analysis of literature data on this topic. Results and discussion. Types of wound healing include primary tension healing, delayed primary tension healing, secondary tension healing, and scab healing. When caring for surgical wounds, primary protection against microorganisms is important. In this case, sterile dressings play an important role, for example, a medical surgical patch with an absorbent pad (Yu-Fix, “Yuria-Pharm”). The pad is characterized by high hygroscopicity, does not stick to the wound and does not leave fibers in the wound. The frequency of dressings changing depends on the healing process and the amount of exudate released from the wound. For festering wounds, the dressing should be changed daily and sometimes more often. Hands and gloves should be worn before bandaging. After removing the gloves, the hands are also treated with an antiseptic (Gorosten, “Yuria-Pharm”, a decamethoxine-based antiseptic). The use of Gorosten in medical institutions for prophylactic purposes is indicated for disinfection of staff hands in order to prevent the spread of transient microflora. Sutures from the surgical wound are removed after the onset of epithelialization, when the wound is covered with a thin protective film. However, in this period there are still wound channels from the threads, so after that it is necessary to treat the wound several times with antiseptic (Dekasan, “Yuria-Pharm”). Signs of local infection of the wound are redness, excess exudate, sometimes – with the addition of pus, odor, pain in the area of injury, fever, edema. Sometimes postsurgical wound suppuration occurs even with proper care due to weak immunity or rejection of surgical suture material. If there is suppuration, it is advisable to switch to dressings with Dekasan and hyperosmolar antibacterial ointments. Unlike 2 % povidone-iodine, which causes severe inhibition of granulation in an open wound, Dekasan does not damage granulation tissue. Surgical treatment, lavage, drainage, antibiotics, laser or ultrasound may also be required. After removing the signs of local inflammation, secondary sutures are applied to the wound or the edges of the wound are connected with the he
背景。伤口是由多种因素引起的皮肤和皮下组织的缺损。伤口护理不仅仅是更换敷料。不同的伤口需要不同的治疗方法和护理。最佳的伤口护理以有效而温和的方式支持自然愈合过程。伤口分为急性和慢性,以及割伤、剥头皮、切碎、刺伤、瘀伤、撕裂、咬伤、枪伤和外科手术。外科伤口的区别在于,它们是专门用于医疗或诊断目的的,在特殊的无菌条件下,在最小的组织创伤下,在麻醉条件下,在彻底止血和用缝合线连接分离的解剖结构的情况下。目标。描述伤口护理的现代方法。材料和方法。本课题的文献资料分析。结果和讨论。伤口愈合的类型包括原发性张力愈合、延迟原发性张力愈合、继发性张力愈合和结痂愈合。在护理外科伤口时,对微生物的初级保护很重要。在这种情况下,无菌敷料发挥重要作用,例如,医用外科贴片与吸收垫(Yu-Fix, " yu - pharm ")。该护垫的特点是吸湿性高,不粘在伤口上,不会在伤口留下纤维。更换敷料的频率取决于愈合过程和伤口渗出物的数量。对于溃烂的伤口,敷料应该每天更换,有时更频繁。包扎前应戴上手和手套。脱下手套后,还要用杀菌剂(Gorosten,“Yuria-Pharm”,一种以十甲氧胺为基础的杀菌剂)处理双手。在医疗机构中,出于预防目的,建议使用Gorosten消毒工作人员的手,以防止瞬态微生物群的传播。当伤口被一层薄薄的保护膜覆盖时,手术伤口上的缝合线在上皮化开始后被拆除。然而,在这一时期仍然有来自线的伤口通道,因此之后有必要用防腐剂多次处理伤口(Dekasan,“Yuria-Pharm”)。伤口局部感染的迹象是发红,渗出物过多,有时还会有脓液,气味,受伤部位疼痛,发烧,水肿。有时即使在适当的护理下,由于免疫功能低下或手术缝合材料的排斥反应,也会发生术后伤口化脓。如果有化脓,建议改用德卡散和高渗抗菌软膏的敷料。不像2%聚维酮碘,会导致严重抑制肉芽在开放的伤口,Dekasan不损害肉芽组织。可能还需要手术治疗、灌洗、引流、抗生素、激光或超声。在消除局部炎症的迹象后,在伤口上进行二次缝合或用胶布连接伤口边缘。在开始伤口护理程序之前,有必要评估伤口床的状况,渗出物的性质,伤口周围组织的状况,疼痛,伤口大小。伤口处理应涉及多学科方法。例如,内分泌学家、糖尿病足专科医生、化脓性外科医生、血管外科医生和护士都参与治疗糖尿病患者的溃疡性缺陷。在伤口治疗中,有必要保持伤口湿润的环境,保持恒温而不降低体温,提供充分的引流而不是过于紧密的填塞,使用额外的愈合手段(例如,在治疗糖尿病患者的足部溃疡时卸载足部)。结论:1。最佳的伤口护理以有效而温和的方式支持自然愈合过程。2. 在护理外科伤口时,防止微生物影响的初级保护是很重要的。3.当伤口被一层薄薄的保护膜覆盖时,手术伤口上的缝合线在上皮化开始后被拆除。4. 如果有化脓,建议改用德卡散和高渗抗菌软膏的敷料。5. 伤口处理应涉及多学科方法。
{"title":"Patient care after surgery: suture care and wound care process","authors":"О. Kovalenko","doi":"10.32902/2663-0338-2020-3.2-138-140","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-138-140","url":null,"abstract":"Background. A wound is a defect of skin and underlying tissues that can be caused by many factors. Wound care is more than just changing dressings. Different wounds require different approaches and care. Optimal wound care supports the natural healing process in an effective but gentle way. Wounds are classified into acute and chronic, as well as cut, scalped, chopped, stabbed, bruised, torn, bitten, gunshot, and surgical. Surgical wounds are distinguished by the fact that they are applied specifically, for medical or diagnostic purposes, in special aseptic conditions, with minimal tissue trauma, in conditions of anesthesia, with thorough hemostasis and joining of separated anatomical structures with sutures. \u0000Objective. To describe the modern approach to wound care. \u0000Materials and methods. Analysis of literature data on this topic. \u0000Results and discussion. Types of wound healing include primary tension healing, delayed primary tension healing, secondary tension healing, and scab healing. When caring for surgical wounds, primary protection against microorganisms is important. In this case, sterile dressings play an important role, for example, a medical surgical patch with an absorbent pad (Yu-Fix, “Yuria-Pharm”). The pad is characterized by high hygroscopicity, does not stick to the wound and does not leave fibers in the wound. The frequency of dressings changing depends on the healing process and the amount of exudate released from the wound. For festering wounds, the dressing should be changed daily and sometimes more often. Hands and gloves should be worn before bandaging. After removing the gloves, the hands are also treated with an antiseptic (Gorosten, “Yuria-Pharm”, a decamethoxine-based antiseptic). The use of Gorosten in medical institutions for prophylactic purposes is indicated for disinfection of staff hands in order to prevent the spread of transient microflora. Sutures from the surgical wound are removed after the onset of epithelialization, when the wound is covered with a thin protective film. However, in this period there are still wound channels from the threads, so after that it is necessary to treat the wound several times with antiseptic (Dekasan, “Yuria-Pharm”). Signs of local infection of the wound are redness, excess exudate, sometimes – with the addition of pus, odor, pain in the area of injury, fever, edema. Sometimes postsurgical wound suppuration occurs even with proper care due to weak immunity or rejection of surgical suture material. If there is suppuration, it is advisable to switch to dressings with Dekasan and hyperosmolar antibacterial ointments. Unlike 2 % povidone-iodine, which causes severe inhibition of granulation in an open wound, Dekasan does not damage granulation tissue. Surgical treatment, lavage, drainage, antibiotics, laser or ultrasound may also be required. After removing the signs of local inflammation, secondary sutures are applied to the wound or the edges of the wound are connected with the he","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87363481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the intermediate results of the INVENT-1 clinical trial: open-label, randomized, multicenter study inind -1临床试验中期结果分析:开放标签、随机、多中心研究
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-78-79
O. Denysov
Background. Attempts to treat tuberculosis (TB) with the help of intravenous drugs have been made since the early XX century. However, XXI century medicine recommends treating TB with pills, and invasive anti-TB drugs (ATBD) are rarely used. International expert groups recommend intravenous administration only for critically ill patients or for patients with absorption disorders. Meanwhile, the advantages of intravenous ATBD include direct monitoring of treatment, accurate dosing for each patient, fewer side effects, and avoidance of taking a large number of tablets. Objective. To evaluate the efficacy, safety, and tolerability of intravenous and oral administration of ATBD in the intensive phase of treatment in patients with advanced destructive pulmonary TB with bacterial excretion. Materials and methods. The study involved 318 patients from 9 clinical centres. The total duration of the study was 18 months. Intravenous and oral administration of isoniazid, rifampicin and ethambutol were compared. The intensive phase of the study lasted 2 months, the maintenance phase lasted 4 months. Inclusion criteria were the following: age 18-65 years, diagnosis of pulmonary TB, at least one positive test result for TB mycobacteria, radiological confirmation of lung destruction and advance TB process, in women – negative urine test for pregnancy, informed consent, negative GenXpert MTB/RIF analysis, and verbal consent to abstain from alcohol during the study. Results and discussion. Due to the resistance to 1st line drugs 14 people were excluded from the study, due to the lack of data on culture – 16 people, for other reasons – 7 people. In the infusion treatment group, 52.63 % had disseminated TB, and 47.37 % had infiltrative TB. In the group of tablet treatment disseminated TB occurred in 35.2 % of patients, infiltrative – in 61.8 %, miliary – in 3 %. At 4th visit, the efficacy of abacillation in both treatment groups was comparable: 34.2 % in the infusion group and 35.26 % in the oral treatment group. But as of the 6th visit, the share of abacillation in the infusion group was 57.42 %, and in the oral treatment group – 46.96 %. Analysis of the time needed to achieve a negative result on mycobacterium TB also revealed the benefits of infusions. Thus, up to the 3rd visit this parameter was reached by 15.78 % of the infusion group patients, and by 13.76 % of oral therapy group patients. The total proportion of patients with a negative test for mycobacterium TB and clinical improvement in the infusion group was 60 %, and in the oral therapy group – 52.90 %. In infiltrative TB, 27.8 % of the infusion group and only 9.5 % of the tablet therapy group reached abacillation by the 3rd visit. In disseminated TB, abacillation was achieved up to 3rd visit in 5 % of the infusion group and 8.3 % of the tablet treatment group, however, the total numbers at the end of the study were 45 and 25 %, respectively. Conclusions. 1. Monitoring the patient’s treatment is a cor
背景。自20世纪初以来,人们就尝试通过静脉注射药物治疗结核病。然而,21世纪的医学建议用药片治疗结核病,侵入性抗结核药物(ATBD)很少被使用。国际专家组建议仅对危重患者或有吸收障碍的患者进行静脉注射。同时,静脉注射ATBD的优点是直接监测治疗情况,准确给药,副作用少,避免大量服用。目标。评估在有细菌排泄的晚期破坏性肺结核患者强化治疗阶段静脉和口服ATBD的有效性、安全性和耐受性。材料和方法。这项研究涉及来自9个临床中心的318名患者。研究的总持续时间为18个月。比较异烟肼、利福平和乙胺丁醇静脉和口服给药情况。强化期为2个月,维持期为4个月。纳入标准如下:年龄18-65岁,诊断为肺结核,至少有一项结核分枝杆菌阳性检测结果,放射学证实肺破坏和结核病进展,女性-妊娠尿试验阴性,知情同意,GenXpert MTB/RIF分析阴性,口头同意在研究期间戒酒。结果和讨论。由于对一线药物的耐药性,14人被排除在研究之外,由于缺乏培养数据- 16人,其他原因- 7人。输液组弥散性结核占52.63%,浸润性结核占47.37%。在片剂治疗组中,弥散性结核发生率为35.2%,浸润性结核发生率为61.8%,军事性结核发生率为3%。在第4次就诊时,两组的去牙效果相当:输注组为34.2%,口服组为35.26%。但截至第6次访视,输液组的乳清比例为57.42%,口服治疗组为- 46.96%。对达到结核分枝杆菌阴性结果所需时间的分析也揭示了输液的好处。因此,到第三次就诊时,15.78%的输液组患者达到了该参数,13.76%的口服治疗组患者达到了该参数。输注组结核分枝杆菌检测阴性且临床好转的患者总比例为60%,口服治疗组为52.90%。在浸润性结核中,输液组27.8%的患者在第3次就诊时达到消音,而片剂组只有9.5%。在播散性结核病中,5%的输注组和8.3%的片剂治疗组在第三次就诊前实现了消融,然而,研究结束时的总数分别为45%和25%。结论:1。监测患者的治疗是结核病治疗的基石。2. 在强化治疗阶段,使用静脉注射ATBD治疗结核病有更大效果的趋势。3.有必要分析治疗的长期结果和两种治疗方案对复发过程的影响。
{"title":"Analysis of the intermediate results of the INVENT-1 clinical trial: open-label, randomized, multicenter study","authors":"O. Denysov","doi":"10.32902/2663-0338-2020-3.2-78-79","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-78-79","url":null,"abstract":"Background. Attempts to treat tuberculosis (TB) with the help of intravenous drugs have been made since the early XX century. However, XXI century medicine recommends treating TB with pills, and invasive anti-TB drugs (ATBD) are rarely used. International expert groups recommend intravenous administration only for critically ill patients or for patients with absorption disorders. Meanwhile, the advantages of intravenous ATBD include direct monitoring of treatment, accurate dosing for each patient, fewer side effects, and avoidance of taking a large number of tablets. \u0000Objective. To evaluate the efficacy, safety, and tolerability of intravenous and oral administration of ATBD in the intensive phase of treatment in patients with advanced destructive pulmonary TB with bacterial excretion. \u0000Materials and methods. The study involved 318 patients from 9 clinical centres. The total duration of the study was 18 months. Intravenous and oral administration of isoniazid, rifampicin and ethambutol were compared. The intensive phase of the study lasted 2 months, the maintenance phase lasted 4 months. Inclusion criteria were the following: age 18-65 years, diagnosis of pulmonary TB, at least one positive test result for TB mycobacteria, radiological confirmation of lung destruction and advance TB process, in women – negative urine test for pregnancy, informed consent, negative GenXpert MTB/RIF analysis, and verbal consent to abstain from alcohol during the study. \u0000Results and discussion. Due to the resistance to 1st line drugs 14 people were excluded from the study, due to the lack of data on culture – 16 people, for other reasons – 7 people. In the infusion treatment group, 52.63 % had disseminated TB, and 47.37 % had infiltrative TB. In the group of tablet treatment disseminated TB occurred in 35.2 % of patients, infiltrative – in 61.8 %, miliary – in 3 %. At 4th visit, the efficacy of abacillation in both treatment groups was comparable: 34.2 % in the infusion group and 35.26 % in the oral treatment group. But as of the 6th visit, the share of abacillation in the infusion group was 57.42 %, and in the oral treatment group – 46.96 %. Analysis of the time needed to achieve a negative result on mycobacterium TB also revealed the benefits of infusions. Thus, up to the 3rd visit this parameter was reached by 15.78 % of the infusion group patients, and by 13.76 % of oral therapy group patients. The total proportion of patients with a negative test for mycobacterium TB and clinical improvement in the infusion group was 60 %, and in the oral therapy group – 52.90 %. In infiltrative TB, 27.8 % of the infusion group and only 9.5 % of the tablet therapy group reached abacillation by the 3rd visit. In disseminated TB, abacillation was achieved up to 3rd visit in 5 % of the infusion group and 8.3 % of the tablet treatment group, however, the total numbers at the end of the study were 45 and 25 %, respectively. \u0000Conclusions. 1. Monitoring the patient’s treatment is a cor","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85733624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infusion therapy of traumatic shock 创伤性休克的输液治疗
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-309-311
V. Chernii
Background. Analysis of all deaths due to military trauma (MT) over the last decade revealed that 1/4 of them could have been prevented. Up to 90 % of these deaths are related to blood loss. Trauma induces acute endogenous coagulopathy within a few minutes in 25 % of patients, which quadruples mortality. The main feature of MT is its combined nature, because in explosive injuries the local action of the explosion is combined with shrapnel wounds and distant damage to organs, and the wound canal goes through several anatomical parts of the body. In case of concomitant injuries, there are several sources of pain impulses, there is a deep endotoxicosis and impaired function of damaged organs. Under MT conditions, it is difficult to determine the nature of the shock due to a combination of hemorrhagic and traumatic shock. Uncontrolled post-traumatic bleeding is the leading cause of preventable death. Objective. To describe infusion therapy (IT) of shock. Materials and methods. Analysis of literature data on this issue. Results and discussion. In approximately 1/3 of hospitalized patients with trauma, the bleeding is coagulopathic. The severity of coagulopathy is determined by the influence of environmental factors, metabolic disorders, therapeutic strategy, the presence of brain and liver injuries, individual characteristics of the patient, the trauma and shock, hemodilution coagulopathy. The primary task of managing a patient with trauma is to eliminate the so-called lethal triad (hypothermia, acidosis, coagulopathy) and ensure perfusion of vital organs. Damage Control Resuscitation (DRC) is a systemic approach to the treatment of severe injuries that combines a resuscitation strategy with a range of surgical techniques from the moment of injury till the end of the treatment. DRC is aimed at blood loss minimization, maximization of tissue oxygenation, and optimization of outcomes. Surgeries performed as part of the DRC approach include an incision from the xiphoid process to the pubis with evacuation of blood and clots from the abdominal cavity, thorough examination and termination of all bleedings. Damaged parenchymal organs are completely resected. Damaged intestine is resected and connected with clips without anastomosis formation. Damaged vessels are ligated. The abdominal cavity is closed with a sterile bandage, but not sutured. After 1-2 days, tampons are removed, anastomoses are formed, and all non-viable tissues are removed. As for examinations, magnetic resonance imaging is the gold standard for assessing the severity of the injury and detecting extraperitoneal bleeding. In patients with closed abdominal trauma, hypotension, or an unknown mechanism of trauma, a rapid ultrasound examination is indicated to look for blood at potential sites of its accumulation. In the treatment of injuries with bleeding and shock, IT is of great importance. Its principles include the restriction of crystalloids use, the use of blood products in the optimal
背景。对过去十年中所有因军事创伤而死亡的分析表明,其中四分之一是可以避免的。这些死亡中高达90%与失血有关。25%的患者外伤会在几分钟内诱发急性内源性凝血功能障碍,使死亡率翻四倍。MT的主要特点是它的复合性,因为在爆炸伤中,爆炸的局部作用与弹片伤和远处器官损伤相结合,伤管贯穿身体的多个解剖部位。在并发损伤的情况下,疼痛冲动有多种来源,存在深度内中毒和受损器官功能受损。在MT条件下,由于出血性和创伤性休克的结合,很难确定休克的性质。不受控制的创伤后出血是可预防死亡的主要原因。目标。描述休克的输液治疗(IT)。材料和方法。对这一问题的文献资料进行分析。结果和讨论。在大约1/3的创伤住院患者中,出血是凝血性的。凝血功能障碍的严重程度取决于环境因素的影响、代谢紊乱、治疗策略、脑和肝损伤的存在、患者的个体特征、创伤和休克、血液稀释凝血功能障碍。处理创伤患者的首要任务是消除所谓的致命三因素(体温过低、酸中毒、凝血功能障碍),并确保重要器官的灌注。损伤控制复苏(DRC)是一种治疗严重损伤的系统方法,它将复苏策略与从受伤时刻到治疗结束的一系列外科技术相结合。DRC旨在最大限度地减少失血,最大限度地提高组织氧合,并优化结果。作为DRC方法的一部分进行的手术包括从剑突到耻骨的切口,从腹腔排出血液和凝块,彻底检查并终止所有出血。受损的实质器官被完全切除。切除受损肠,用夹片连接,不形成吻合。结扎受损血管。腹腔用无菌绷带包扎,但不缝合。1-2天后,去除卫生棉条,形成吻合口,去除所有不能存活的组织。在检查方面,磁共振成像是评估损伤严重程度和检测腹膜外出血的金标准。对于闭合性腹部创伤、低血压或创伤机制未知的患者,建议快速超声检查以寻找潜在积血部位的血液。在出血和休克损伤的治疗中,信息技术是非常重要的。其原则包括限制晶体类药物的使用,在血液和血浆的最佳比例下使用血液制品,以及降压直到最后手术止血。Reosorbilact(“Yuria-Pharm”)具有接近理想输注溶液的特性。一项多中心的Rheo-STAT研究证实了Reosorbilact对休克的疗效。外伤性休克时,滴注800 ml Reosorbilact不影响凝血止血系统。相反,施用同样体积的0.9%氯化钠会出现高凝倾向,500ml羟乙基淀粉则会出现低凝倾向。Reosorbilact具有明显的快速血流动力学作用。创伤出血患者的目标血红蛋白水平为70-90 g/L。静脉注射铁制剂(Sufer,“豫药”)可用于其纠正。建议院前输血使凝血指标正常化。氨甲环酸(Sangera,“Yuria-Pharm”)应在受伤后3小时内给予出血患者。第一剂应在院前护理阶段给予。桑格拉具有抗纤溶、抗过敏、抗炎等多种作用。此外,桑格拉2-3倍降低疼痛敏感阈值。综合治疗出血的另一个推荐成分是引入氯化钙。重组活化凝血因子7不推荐常规用药,只有当其他措施无效时才开处方。建议立即停用维生素K拮抗剂,并使用适当的解毒剂。肺栓塞是多创伤患者存活第三天的第三大常见死因。建议在出血控制后24小时内开始药物血栓预防。结论:1。很大一部分可预防的死亡与失血有关。2.
{"title":"Infusion therapy of traumatic shock","authors":"V. Chernii","doi":"10.32902/2663-0338-2020-3.2-309-311","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-309-311","url":null,"abstract":"Background. Analysis of all deaths due to military trauma (MT) over the last decade revealed that 1/4 of them could have been prevented. Up to 90 % of these deaths are related to blood loss. Trauma induces acute endogenous coagulopathy within a few minutes in 25 % of patients, which quadruples mortality. The main feature of MT is its combined nature, because in explosive injuries the local action of the explosion is combined with shrapnel wounds and distant damage to organs, and the wound canal goes through several anatomical parts of the body. In case of concomitant injuries, there are several sources of pain impulses, there is a deep endotoxicosis and impaired function of damaged organs. Under MT conditions, it is difficult to determine the nature of the shock due to a combination of hemorrhagic and traumatic shock. Uncontrolled post-traumatic bleeding is the leading cause of preventable death. \u0000Objective. To describe infusion therapy (IT) of shock. \u0000Materials and methods. Analysis of literature data on this issue. \u0000Results and discussion. In approximately 1/3 of hospitalized patients with trauma, the bleeding is coagulopathic. The severity of coagulopathy is determined by the influence of environmental factors, metabolic disorders, therapeutic strategy, the presence of brain and liver injuries, individual characteristics of the patient, the trauma and shock, hemodilution coagulopathy. The primary task of managing a patient with trauma is to eliminate the so-called lethal triad (hypothermia, acidosis, coagulopathy) and ensure perfusion of vital organs. Damage Control Resuscitation (DRC) is a systemic approach to the treatment of severe injuries that combines a resuscitation strategy with a range of surgical techniques from the moment of injury till the end of the treatment. DRC is aimed at blood loss minimization, maximization of tissue oxygenation, and optimization of outcomes. Surgeries performed as part of the DRC approach include an incision from the xiphoid process to the pubis with evacuation of blood and clots from the abdominal cavity, thorough examination and termination of all bleedings. Damaged parenchymal organs are completely resected. Damaged intestine is resected and connected with clips without anastomosis formation. Damaged vessels are ligated. The abdominal cavity is closed with a sterile bandage, but not sutured. After 1-2 days, tampons are removed, anastomoses are formed, and all non-viable tissues are removed. As for examinations, magnetic resonance imaging is the gold standard for assessing the severity of the injury and detecting extraperitoneal bleeding. In patients with closed abdominal trauma, hypotension, or an unknown mechanism of trauma, a rapid ultrasound examination is indicated to look for blood at potential sites of its accumulation. In the treatment of injuries with bleeding and shock, IT is of great importance. Its principles include the restriction of crystalloids use, the use of blood products in the optimal","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78038526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Artificial blood: where are we now? 人工血液:我们现在在哪里?
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-14-16
Amany A.E. Ahmed
Background. The creation of artificial blood (AB) and/or its components can change medicine, but currently available artificial oxygen carriers (AOC) do not perform other blood functions: vascular volume maintenance, coagulation, immunity, transport of neurotransmitters, nutrients and waste. Objective. To describe the current situation regarding AB. Materials and methods. Analysis of literature data on this issue. Results and discussion. The need to create an AB is justified by the high cost of collecting, processing and storing donor blood, low infectious safety of drugs received against HIV, viral hepatitis B and C, cytomegalovirus, etc., reduction of the number of donors, problems with blood incompatibility. Immunological effects of blood transfusions are associated with a higher frequency of infectious processes during surgery, slowing of wound healing and progression of malignant diseases. Requirements for an ideal AB preparation include adequate oxygen uptake and delivery under physiological conditions, no toxic or physiological effects, ability to be eliminated and excreted by the human body, sufficient intravascular half-life, ease of use and storage, stability at room temperature, universal compatibility, availability and low cost, ability to maintain blood pressure and pH, viscosity similar to real blood. Available AOC include oxygen-transport solutions based on hemoglobin and perfluorocarbon compounds (PFC) in the form of emulsions. Natural (human, bovine) or genetically modified hemoglobin is used for the production of the former, and hemoglobin of yeast or bacterial origin can also be used. The advantages of hemoglobin solutions include the increased erythropoietin production, adequate oxygen delivery at a hemoglobin level of 20 g/L without side effects, complete absence of virus transmission and 25 % better reperfusion recovery than with real blood. Potential fields of AOC use include shock, organ ischemia, erythrocyte incompatibility, acute lung injury, organ storage for transplantation, cardioplegia, sickle cell anemia, tumor treatment, and air embolism. The main problem is the release of pro-inflammatory cytokines in response to hemoglobin solution administration. Side effects of these solutions include neuro- and nephrotoxicity, immunosuppression, vasoconstriction, coagulopathy, release of free radicals, and errors in blood tests. In turn, PFC does not bind oxygen, but dissolves it in proportion to the partial pressure. PFC are eliminated by phagocytes and eventually excreted by the lungs during respiration. PFC particles are much smaller than natural erythrocytes (0.2 vs. 7 μm) and are easier to deform, which facilitates their delivery to ischemic areas. Side effects of PFC include transient face flushing, headache and back pain, nausea, fever, anaphylactoid reactions, bleeding tendency, pulmonary edema, and acute right ventricular failure. Because high partial pressures are required to achieve the desired PFC effects, artif
背景。人工血液(AB)和/或其成分的产生可以改变药物,但目前可用的人工氧载体(AOC)不执行其他血液功能:血管容量维持、凝血、免疫、神经递质运输、营养物质和废物。目标。描述AB材料和方法的现状。对这一问题的文献资料进行分析。结果和讨论。由于采集、处理和储存献血者血液的成本较高,抗艾滋病毒、病毒性乙型和丙型肝炎、巨细胞病毒等药物的感染安全性较低,献血者数量减少,以及血液不相容的问题,因此有必要创建AB。输血的免疫效应与手术过程中感染过程的较高频率、伤口愈合的减慢和恶性疾病的进展有关。理想的AB制剂的要求包括生理条件下足够的氧气摄取和输送,无毒性或生理效应,能够被人体消除和排泄,足够的血管内半衰期,易于使用和储存,室温稳定性,通用兼容性,可用性和低成本,维持血压和pH值的能力,粘度类似于真正的血液。可用的AOC包括基于血红蛋白和全氟碳化合物(PFC)的乳剂形式的氧传输溶液。前者的生产使用天然(人、牛)或转基因血红蛋白,酵母或细菌血红蛋白也可以使用。血红蛋白溶液的优点包括红细胞生成素的产生增加,血红蛋白水平为20 g/L时的充足氧气输送,无副作用,完全没有病毒传播,再灌注恢复比真血好25%。AOC应用的潜在领域包括休克、器官缺血、红细胞不相容、急性肺损伤、器官移植储存、心脏骤停、镰状细胞性贫血、肿瘤治疗和空气栓塞。主要的问题是促炎细胞因子的释放对血红蛋白溶液的反应。这些溶液的副作用包括神经和肾毒性、免疫抑制、血管收缩、凝血功能障碍、自由基释放和血液检查错误。反过来,PFC不结合氧气,而是按分压的比例溶解氧气。PFC被吞噬细胞清除,最终在呼吸过程中由肺排出。PFC颗粒比天然红细胞小得多(0.2 μm vs. 7 μm),更容易变形,这有利于它们递送到缺血区域。PFC的副作用包括短暂的面部潮红、头痛和背痛、恶心、发烧、类过敏反应、出血倾向、肺水肿和急性右心室衰竭。由于需要较高的分压才能达到预期的PFC效果,因此可能需要人工肺通气。除了基于血红蛋白的AOC和PFC,血红蛋白脂质体红细胞形式,血红蛋白纳米胶囊,血红蛋白纳米结构复合物正在开发中。结论:1。AB的诞生可能会给医学带来革命性的变化。2. 由于献血者血液的收集、处理和储存成本高、感染安全性低、献血者数量减少以及血液不相容造成的问题,建立AB的必要性是合理的。3.AOC包括基于血红蛋白的氧转运溶液和PFC乳剂。4. 需要进一步的研究来改进现有的AB制剂,并创建新的AB制剂。
{"title":"Artificial blood: where are we now?","authors":"Amany A.E. Ahmed","doi":"10.32902/2663-0338-2020-3.2-14-16","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-14-16","url":null,"abstract":"Background. The creation of artificial blood (AB) and/or its components can change medicine, but currently available artificial oxygen carriers (AOC) do not perform other blood functions: vascular volume maintenance, coagulation, immunity, transport of neurotransmitters, nutrients and waste. \u0000Objective. To describe the current situation regarding AB. \u0000Materials and methods. Analysis of literature data on this issue. \u0000Results and discussion. The need to create an AB is justified by the high cost of collecting, processing and storing donor blood, low infectious safety of drugs received against HIV, viral hepatitis B and C, cytomegalovirus, etc., reduction of the number of donors, problems with blood incompatibility. Immunological effects of blood transfusions are associated with a higher frequency of infectious processes during surgery, slowing of wound healing and progression of malignant diseases. Requirements for an ideal AB preparation include adequate oxygen uptake and delivery under physiological conditions, no toxic or physiological effects, ability to be eliminated and excreted by the human body, sufficient intravascular half-life, ease of use and storage, stability at room temperature, universal compatibility, availability and low cost, ability to maintain blood pressure and pH, viscosity similar to real blood. Available AOC include oxygen-transport solutions based on hemoglobin and perfluorocarbon compounds (PFC) in the form of emulsions. Natural (human, bovine) or genetically modified hemoglobin is used for the production of the former, and hemoglobin of yeast or bacterial origin can also be used. The advantages of hemoglobin solutions include the increased erythropoietin production, adequate oxygen delivery at a hemoglobin level of 20 g/L without side effects, complete absence of virus transmission and 25 % better reperfusion recovery than with real blood. Potential fields of AOC use include shock, organ ischemia, erythrocyte incompatibility, acute lung injury, organ storage for transplantation, cardioplegia, sickle cell anemia, tumor treatment, and air embolism. The main problem is the release of pro-inflammatory cytokines in response to hemoglobin solution administration. Side effects of these solutions include neuro- and nephrotoxicity, immunosuppression, vasoconstriction, coagulopathy, release of free radicals, and errors in blood tests. In turn, PFC does not bind oxygen, but dissolves it in proportion to the partial pressure. PFC are eliminated by phagocytes and eventually excreted by the lungs during respiration. PFC particles are much smaller than natural erythrocytes (0.2 vs. 7 μm) and are easier to deform, which facilitates their delivery to ischemic areas. Side effects of PFC include transient face flushing, headache and back pain, nausea, fever, anaphylactoid reactions, bleeding tendency, pulmonary edema, and acute right ventricular failure. Because high partial pressures are required to achieve the desired PFC effects, artif","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"199 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76389155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peculiarities of care for patients with coronavirus infection. Important safety issues for health care workers 冠状病毒感染患者护理的特殊性。卫生保健工作者的重要安全问题
Pub Date : 2020-12-15 DOI: 10.32902/2663-0338-2020-3.2-254-256
A. Savych
Background. In case of coronavirus disease (COVID-19), contact persons include, but are not limited to, health care workers (HCW) and caregivers of COVID-19 patients. Personal protective equipment is required for HCW working with patients or individuals with suspected COVID-19. Correct sequence and the correct technique of putting them on is very important. Objective. To describe the safety measures for HCW in care of patients with COVID-19. Materials and methods. Analysis of literature sources on this topic. Results and discussion. Contaminated environmental surfaces take part in the contact route of transmission. To reduce the role of fomites in the transmission of the new SARS-CoV-2 coronavirus, special recommendations of the Ministry of Health on surface cleaning and disinfection have been developed. After cleaning, disinfectants must be used to reduce the viral load on the surface. These disinfectants are also effective against other pathogens that are important in health care settings. Such agents include ethanol 70-90 %, chlorine-based agents, and hydrogen peroxide >0.5 %. The register of disinfectants of Ukraine contains more than 200 brands. The vast majority of them are represented by alcohol- and chlorine-containing solutions of various concentrations, colors and odors. The use of these solutions is limited to the torso and extremities. These solutions have a number of limitations and caveats in their use. For instance, in case of contact with mucous membranes, they have an irritating effect and require rinsing with plenty of water. Vapors of some of them should not be inhaled, so they should be used in well-ventilated areas or with protective equipment. Alcohol-based products should not be applied to damaged areas of the skin due to protein denaturation. The Food and Drug Administration (FDA) recommends to use the chlorine- and alcohol-based solutions with caution due to the lack of evidence of their safety. The decamethoxine-based solution Yusept (“Yuria-Pharm”) is intended for disinfection of hands and other parts of the body, including the face; for disinfection of HCW gloves and gloves in other places; for disinfection and pre-sterilization cleaning of all medical devices from various materials; for disinfection of hairdresser’s, manicure, pedicure and cosmetic accessories; for disinfection of rooms, furniture, patient care items, hygiene products, utensils, containers, sanitary equipment, rubber carpets; for current, final and preventive disinfection; for use in aerosol disinfection systems such as Yu-box and other disinfection systems. Proper hand washing technique is also an important preventive measure. The effectiveness of prevention of HCW infection during their professional duties depends on how serious the problem is taken by the management of the health care institution and the HCW, who work with infectious patients, themselves. Conclusions. 1. For HCW working with patients or persons with suspected COVID-19, the use
背景。在冠状病毒病(COVID-19)情况下,接触者包括但不限于卫生保健工作者和COVID-19患者的护理人员。与疑似COVID-19患者或个人一起工作的医护人员需要个人防护装备。正确的顺序和正确的方法是非常重要的。目标。描述在COVID-19患者护理中使用hcv的安全措施。材料和方法。对这一主题的文献来源进行分析。结果和讨论。受污染的环境表面参与了接触途径的传播。为减少污染物在新型SARS-CoV-2冠状病毒传播中的作用,卫生部制定了关于表面清洁和消毒的特别建议。清洁后,必须使用消毒剂,以减少表面的病毒载量。这些消毒剂对卫生保健机构中重要的其他病原体也有效。这些试剂包括乙醇70- 90%,氯基试剂和过氧化氢> 0.5%。乌克兰注册的消毒剂有200多个品牌。它们中的绝大多数是不同浓度、颜色和气味的含酒精和含氯溶液。这些解决方案的使用仅限于躯干和四肢。这些解决方案在使用中有许多限制和注意事项。例如,在接触粘膜的情况下,它们有刺激作用,需要用大量的水冲洗。其中部分产品的蒸气不宜吸入,应在通风良好的地方使用,或配备防护装备。酒精类产品不应应用于因蛋白质变性而受损的皮肤区域。美国食品和药物管理局(FDA)建议谨慎使用氯和酒精溶液,因为没有证据表明它们的安全性。以十甲氧胺为基础的溶液Yusept(“Yuria-Pharm”)用于手部和身体其他部位(包括面部)的消毒;用于消毒HCW手套和其他场所的手套;用于各种材质的医疗器械的消毒和预灭菌清洗;用于消毒美发、修甲、足疗及化妆品配件;用于房间、家具、病人护理用品、卫生用品、器皿、容器、卫生设备、橡胶地毯的消毒;用于当前、最终和预防性消毒;用于气溶胶消毒系统,如Yu-box和其他消毒系统。正确的洗手方法也是重要的预防措施。在其专业职责期间预防艾滋病毒/艾滋病感染的有效性取决于卫生保健机构的管理人员和与感染患者打交道的艾滋病毒/艾滋病护理人员本身对这个问题的重视程度。结论:1。与患者或疑似COVID-19患者一起工作的医护人员必须使用个人防护装备。2. 受污染的表面参与了感染传播的接触途径的实施。3.绝大多数消毒液是含酒精和含氯的,在使用中有一些限制和注意事项。4. Yusept溶液用于手部和身体其他部位(包括面部)的消毒;用于所有医疗器械的消毒和灭菌前清洗;用于房间、家具、病人护理用品的消毒;用于气溶胶消毒系统。
{"title":"Peculiarities of care for patients with coronavirus infection. Important safety issues for health care workers","authors":"A. Savych","doi":"10.32902/2663-0338-2020-3.2-254-256","DOIUrl":"https://doi.org/10.32902/2663-0338-2020-3.2-254-256","url":null,"abstract":"Background. In case of coronavirus disease (COVID-19), contact persons include, but are not limited to, health care workers (HCW) and caregivers of COVID-19 patients. Personal protective equipment is required for HCW working with patients or individuals with suspected COVID-19. Correct sequence and the correct technique of putting them on is very important. \u0000Objective. To describe the safety measures for HCW in care of patients with COVID-19. \u0000Materials and methods. Analysis of literature sources on this topic. \u0000Results and discussion. Contaminated environmental surfaces take part in the contact route of transmission. To reduce the role of fomites in the transmission of the new SARS-CoV-2 coronavirus, special recommendations of the Ministry of Health on surface cleaning and disinfection have been developed. After cleaning, disinfectants must be used to reduce the viral load on the surface. These disinfectants are also effective against other pathogens that are important in health care settings. Such agents include ethanol 70-90 %, chlorine-based agents, and hydrogen peroxide >0.5 %. The register of disinfectants of Ukraine contains more than 200 brands. The vast majority of them are represented by alcohol- and chlorine-containing solutions of various concentrations, colors and odors. The use of these solutions is limited to the torso and extremities. These solutions have a number of limitations and caveats in their use. For instance, in case of contact with mucous membranes, they have an irritating effect and require rinsing with plenty of water. Vapors of some of them should not be inhaled, so they should be used in well-ventilated areas or with protective equipment. Alcohol-based products should not be applied to damaged areas of the skin due to protein denaturation. The Food and Drug Administration (FDA) recommends to use the chlorine- and alcohol-based solutions with caution due to the lack of evidence of their safety. The decamethoxine-based solution Yusept (“Yuria-Pharm”) is intended for disinfection of hands and other parts of the body, including the face; for disinfection of HCW gloves and gloves in other places; for disinfection and pre-sterilization cleaning of all medical devices from various materials; for disinfection of hairdresser’s, manicure, pedicure and cosmetic accessories; for disinfection of rooms, furniture, patient care items, hygiene products, utensils, containers, sanitary equipment, rubber carpets; for current, final and preventive disinfection; for use in aerosol disinfection systems such as Yu-box and other disinfection systems. Proper hand washing technique is also an important preventive measure. The effectiveness of prevention of HCW infection during their professional duties depends on how serious the problem is taken by the management of the health care institution and the HCW, who work with infectious patients, themselves. \u0000Conclusions. 1. For HCW working with patients or persons with suspected COVID-19, the use ","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"65 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78752976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infusion & Chemotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1